From Nairobi to Beijing-Essential Medicines in China Past, Present & Future-From List to Comprehensive Policy | Duke Kunshan University
From Nairobi to Beijing-Essential Medicines in China Past, Present & Future-From List to Comprehensive Policy
Speaker: 
Dr. Jing Sun

Associate Professor of pharmaceutical policy of Chinese Academy of Medical Science (CAMS), Peking Union Medical College (PUMC) School of Public Health

Oct 14th 2015 12:15 to 13:15
Room 1079, Academic Building
Wednesday, January 17, 2018 - 18:00

Summary of Talk:

The Lancet has commissioned a group of 19 independent public health and medical experts from around the world—with analyzing progress made in global essential medicines policies over the last 30 years to achieve broader global health goals, especially universal health coverage, and making recommendations for the next two decades. The experts plan to issue a report and publish it in March 2016, 30 years after the Nairobi Conference on the Rational Use of Drugs, which was convened by the World Health Organization in November 1985.

As one of the 19 independent experts, Dr Sun Jing will take the opportunity of meeting and talking with the academics from Kunshan Duke University, talking about the key messages from the Nairobi Conference, the international development of essential medicines after the Nairobi Conference, and the past, present & future development of essential medicines in China.

 

Brief Biography:

Jing Sun is an associate professor of pharmaceutical policy of Chinese Academy of Medical Science (CAMS), Peking Union Medical College (PUMC) School of Public Health. She is also the leader of Pharmaceutical Policy Theme Group of China Core Group of the International Network Rational Use of Drug (INRUD) and the country leader of BRICS Medicines Alliance.

The extensive work experiences in national lab, national regulatory authority, international health organization, research and academic institutes render her knowledge and skills in pharmaceutical science, project management and policy research. Her research areas focus on macro pharmaceutical policy and initiatives to improve the use of medicines. Since 2004, she has been involved in providing technical support to the Chinese government in the pharmaceutical area, and contributed to China’s national health system reform, especially the reforms in the pharmaceutical sector.

Dr. Sun received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen. She received her MSc. of International Health Policy from London School of Economics and her Bachelor of Pharmaceutical Chemistry from Peking University.